⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELAN News
Elanco Animal Health Incorporated Common Stock
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
globenewswire.com
CANF
ELAN
ZOETIS
Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats
prnewswire.com
ELAN
Elanco to Participate in the Upcoming Investor Conferences
prnewswire.com
ELAN
Elanco Animal Health Reports Third Quarter 2025 Results
prnewswire.com
ELAN
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
prnewswire.com
ELAN
ELAN
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
prnewswire.com
ELAN
ELAN
Elanco to Host Investor Day on December 9
prnewswire.com
ELAN
ELAN
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
prnewswire.com
ELAN
ELAN
Elanco Innovation Builds Momentum, Credelio Quattro(TM) (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Reaches Blockbuster Status
accessnewswire.com
ELAN
ELAN
Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status
prnewswire.com
ELAN
ELAN